share_log

NEXGEL to Participate in the IAccess Alpha Virtual Best Ideas Winter Conference on December 10-11, 2024

NEXGEL to Participate in the IAccess Alpha Virtual Best Ideas Winter Conference on December 10-11, 2024

NEXGEL將參加2024年12月10日至11日舉行的IAccess Alpha Virtual最佳創意冬季會議。
GlobeNewswire ·  11/21 09:00

LANGHORNE, Pa., Nov. 21, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. ("NEXGEL" or the "Company") (NASDAQ: "NXGL"), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogels for healthcare and consumer applications, today announced that Adam Levy, Chief Executive Officer, will present at the iAccess Alpha Virtual Best Ideas Winter Conference 2024 on December 10 and 11, 2024.

賓夕法尼亞州蘭霍恩,2024年11月21日(環球新聞專線)——醫療和非處方(OTC)產品的領先提供商NEXGEL公司(「NEXGL」 或 「公司」)(納斯達克股票代碼:「NXGL」)今天宣佈,首席執行官亞當·利維將出席iAccess Alpha Virtual Best 2024 年 Ideas 冬季會議將於 2024 年 12 月 10 日和 11 日舉行。

iAccess Alpha Virtual Conference Details:
Date: December 10-11, 2024
Presentation Day and Time: Tuesday, December 10th at 10:30 a.m. ET
Webcast:

iAccess Alpha 虛擬會議詳情:
日期:2024 年 12 月 10 日至 11 日
演講日期和時間:美國東部時間12月10日星期二上午10點30分
網絡直播:

To schedule a one-on-one investor meeting with Mr. Levy, please contact your representatives at iAccess or email KCSA Strategic Communications at NEXGEL@KCSA.Com.

要安排與利維先生進行一對一的投資者會議,請通過iAccess聯繫您的代表或發送電子郵件給KCSA Strategic Communications,地址爲 NEXGEL@KCSA.Com.

About NEXGEL, Inc.

關於 NEXGEL, Inc.

NEXGEL is a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogels. Based in Langhorne, Pa., the Company has developed and manufactured electron-beam, cross-linked hydrogels for over two decades. NEXGEL brands include SilverSeal, Hexagels, Turfguard, Kenkoderm and Silly George. Additionally, NEXGEL has strategic contract manufacturing relationships with leading consumer healthcare companies.

NEXGEL 是醫療保健、美容和非處方 (OTC) 產品的領先供應商,包括超溫和、高水含量的水凝膠。該公司總部位於賓夕法尼亞州蘭霍恩,開發和製造電子束交聯水凝膠已有二十多年了。NEXGEL 品牌包括 SilverSeal、Hexagels、Turfguard、Kenkoderm 和 Silly George。此外,NEXGEL與領先的消費者醫療保健公司建立了戰略合同製造關係。

Investor Contacts:
Valter Pinto, Managing Director
KCSA Strategic Communications
212.896.1254
NEXGEL@KCSA.com

投資者聯繫人:
瓦爾特·平託,董事總經理
KCSA 戰略傳播
212.896.1254
NEXGEL@KCSA.com


声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論